Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Dolutegravir
Dolutegravir
GlaxoSmithKline and Pfizer's HIV Joint Venture Gets Priority Review for Dolutegravir
Motley Fool
Sat, 02/16/13 - 11:58 am
GSK
Pfizer
HIV
Dolutegravir
GSK wins priority status for new HIV drug in U.S.
Reuters
Fri, 02/15/13 - 11:23 am
GSK
HIV
Shionogi
ViiV Healthcare
Dolutegravir
Glaxo Future Hangs in Balance on 2013 U.S. Drug Approvals
Bloomberg
Fri, 01/11/13 - 11:56 am
GSK
drug approvals
albiglutide
relvar
Dolutegravir
Shionogi applies for HIV drug approval in U.S., Europe
Reuters
Tue, 12/18/12 - 11:14 am
Shionogi
HIV
FDA
Europe
Dolutegravir
ViiV Healthcare
Glaxo-Pfizer HIV Drug Helps Hard-to-Treat Patients
Bloomberg
Thu, 11/15/12 - 10:53 am
GSK
Pfizer
HIV
Dolutegravir
Shionogi
Shionogi to take 10 pct stake in GSK, Pfizer HIV drug venture
Reuters
Mon, 10/29/12 - 10:32 am
Shionogi
GSK
Pfizer
HIV
Dolutegravir
GlaxoSmithKline Reports Completion Of Dolutegravir Registration Package
NASDAQ.com
Thu, 10/4/12 - 10:46 am
GSK
Dolutegravir
Shionogi-ViiV
HIV
Glaxo, Shionogi Say HIV Drug Beats Gilead Atripla In Test
Bloomberg
Wed, 07/11/12 - 10:19 am
GSK
HIV
AIDS
Shionogi
Gilead
Atripla
Dolutegravir
GSK Sets Stage for Big Late-Stage Drug Events, Potential Blockbusters
Motley Fool
Wed, 11/2/11 - 11:14 am
GSK
Relovair
IPX066
Dolutegravir
Glaxo-Pfizer AIDS Pill May Dislodge Bristol’s, Study Suggests
Bloomberg
Tue, 07/19/11 - 12:22 pm
AIDS
HIV
GSK
Pfizer
Bristol-Myers Squibb
Dolutegravir
Sustiva
ViiV Healthcare
Pages
« first
‹ previous
1
2